Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2500114	艾贝格司亭α注射液	efbemalenograstim alfa	Injection	Biological Products	Supplementary Application	2025-05-20	Evive Biopharmaceutical (Beijing) Ltd;Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group	view
CXSS2200018	艾贝格司亭α注射液	efbemalenograstim alfa	Injection	Biological Products(1)	New Drug Application	2022-02-25	Evive Biopharmaceutical (Beijing) Ltd	view
CYSB2500001	艾贝格司亭α注射液	efbemalenograstim alfa	Injection	Biological Products(1)	Supplementary Application	2025-01-03	Evive Biopharmaceutical (Beijing) Ltd	view
CYSB2400310	艾贝格司亭α注射液	efbemalenograstim alfa	Injection	Biological Products(1)	Supplementary Application	2024-12-03	Evive Biopharmaceutical (Beijing) Ltd	view
CYSB2400186	艾贝格司亭α注射液	efbemalenograstim alfa	Injection	Biological Products(1)	Supplementary Application	2024-07-25	Evive Biopharmaceutical (Beijing) Ltd	view